Hundreds of pharmaceutical companies have mobilized thousands of workers and millions of dollars to produce a coronavirus vaccine as fast as humanly possible, lured by the promise of tremendous revenues...
The quest for a coronavirus vaccine
Scientists worldwide are rushing to create a coronavirus vaccine. That's causing ethical conundrums, as safety protocols are sidestepped in favor of speed. Meanwhile, some scientists are convinced that any vaccine will only confer short-term immunity, and that reinfection is possible no matter what.
The coronavirus quarantine might last far longer than expected. A new study suggests that individual immunity to COVID-19 may not last more than a couple of months, meaning that a person could become It's...
This article originally appeared on ProPublica. It's been six months since researchers in China said they had identified a novel coronavirus spreading in the city of Wuhan. Hope and desire for a vaccine...
Every week since the start of the pandemic has brought new headlines about a coronavirus vaccine. In early June, there was news about human trials starting for a Johnson & Johnson vaccine; also in June,...
The pharmaceutical company Johnson & Johnson announced Wednesday that it is going to begin its human trial phase of developing a potential coronavirus vaccine in the second half of July, rather than September...
A new study reveals that roughly half of Americans either would not get a coronavirus vaccine if scientists succeed in creating one, or have not made up their minds about whether they would do so. The...
Promising early results released Monday from a phase-1 COVID-19 vaccine trial by the biotech firm Moderna led to a rare optimistic wave of media attention. The news adorned headlines at media outlets CNN...